Survival Rates and Longterm Outcomes After COVID-19
Survival Rates and Long-term Outcomes for Patients With COVID-19 Admitted to Norwegian ICUs
1 other identifier
observational
860
1 country
1
Brief Summary
The study 'Survival rates and long-term outcomes for patients with COVID-19 admitted to Norwegian ICUs' is a national observational study, including patients admitted to a Norwegian ICU between March 2020 and March 2021. The study will describe survival rates, clinical characteristics and health challenges experienced by survivors the first year after ICU admission caused by COVID-19 disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2022
CompletedJuly 15, 2022
July 1, 2022
10 months
October 15, 2020
July 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ICU Survival rate
Time to survival
up to 30 days
Change in Functional Status
Measured by self-reporting using Lawton Instrumental activity of daily living. Higher score indicates better function, and ranges from 0-8.
6 and 12 months after ICU admission
Secondary Outcomes (3)
Change in Anxiety and Depression
Measured 6 and 12 months after ICU admission
Changes in Cognitive Status
Measured at 6 and 12 months after ICU admission
Change in Quality of Life 6 and 12 months after ICU admission
Measured 6 and 12 months after ICU admission
Interventions
This is an observational study, so all patients will undergo a variation of ICU treatment, and we will record that information (e.g., time on ventilator, time in ICU, SAPS score at admission)
Eligibility Criteria
All patients that have been admitted to a Norwegian ICU with confirmed COVID-19, and not reserved them against the national register, will be contacted for inclusion to the study.
You may qualify if:
- Patients registered in Norwegian Intensive Care Register, that are ≥ 18 years with confirmed cases of COVID-19.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- The Research Council of Norwaycollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0027, Norway
Related Publications (1)
Laake JH, Hagen M, Aavitsland P, Buanes EA, Fjone KS, Kvale R, Olsen BF, Hofso K. COVID-19 in Norwegian ICUs 2020-2023: Patient characteristics, management, and outcomes-A nationwide prospective observational study. Acta Anaesthesiol Scand. 2025 Apr;69(4):e70027. doi: 10.1111/aas.70027.
PMID: 40114460DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristin Hofsø, PhD
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 23, 2020
Study Start
September 16, 2020
Primary Completion
June 30, 2021
Study Completion
July 10, 2022
Last Updated
July 15, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share